|
|
| |
|
|
|
|
|
|
539 |
°¿ø |
°¸ª¾Æ»êº´¿ø ´ëÇѽÉÀåÇÐȸ °¿øÁöȸ Á¦29Â÷ Ãß°è½ÉÆ÷Áö¾ö : 2019-11-02 |
0 |
462 |
2019-10-11 |
|
|
|
538 |
¼¿ï |
¼ºÀμ±Ãµ¼º½ÉÀ庴¿¬±¸È¸ Korean ACHD symposium 2019 : 2019-11-16 |
0 |
458 |
2019-10-24 |
|
|
|
537 |
ºÎ»ê |
2019³âµµ Á¦44ȸ ºÎ»ê±¤¿ª½ÃÀÇ»çȸ Çмú´ëȸ ¹× ºÎ»ê±¤¿ª½Ã ÀÇ»çÀÇ ³¯ ±â³äÇà»ç : 2019-11-16 |
0 |
458 |
2019-10-12 |
|
|
|
536 |
¼¿ï |
°¡Á·Á¢ÃËÀÚ °ËÁø ÀÇ·á±â°ü ÀÇ·áÁø ´ë»ó °áÇÙ ¹× Àẹ°áÇÙ°¨¿°°ü¸® ±³À° 2±â(¼¿ï/11¿ù27ÀÏ) : 2019-11-27 |
0 |
456 |
2019-11-15 |
|
|
|
535 |
¼¿ï |
2019³â ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-08 |
0 |
456 |
2019-10-29 |
|
|
|
534 |
´ë±¸ |
2019 ´ë±¸±¤¿ª½Ã ºÏ±¸ÀÇ»çȸ °³¿øÀÇ ¿¬¼ö°Á : 2019-11-20 |
0 |
456 |
2019-10-24 |
|
|
|
533 |
´ëÀü |
1)Second look of 5 reductase inhibitors focusing on adverse events 2)³²¼º³ÀÓ, ºñ´¢±â°ú ÀÇ»çÀÇ ¿ªÇÒÀº? : 2019-11-19 |
0 |
451 |
2019-10-29 |
|
|
|
532 |
´ëÀü |
2019 ´ëÇѳ»ºÐºñÇÐȸ Çп¬»ê ¹× Ãß°èÇмú´ëȸ : 2019-11-02 |
0 |
450 |
2019-10-04 |
|
|
|
531 |
°¿ø |
°¿ø´ëÇб³º´¿ø ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ °¿øÁöȸ 11¿ù ¿¬¼ö°Á : 2019-11-29 |
0 |
448 |
2019-11-07 |
|
|
|
530 |
¼¿ï |
¼¼ºê¶õ½ºº´¿ø 2Çбâ À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ (À̺ñÀÎÈÄ°úÀÇ»çµéÀÌ Àß ¸ð¸£´Â ÅΰüÀý ÁýÁߎ±¸) : 2019-11-21 |
0 |
443 |
2019-10-29 |
|
|
|
529 |
¼¿ï |
Çѱ¹ÀÇ·áÀ±¸®ÇÐȸ ÀÇÇבּ¸À±¸®¸¦ µÇµ¹¾Æº»´Ù : 2019-11-30 |
0 |
441 |
2019-11-07 |
|
|
|
528 |
ºÎ»ê |
ºÎ»ê½Ã ÇØ¿î´ë±¸ÀÇ»çȸ 11¿ù Çмúȸ(¿ª·ù¼º ½Äµµ¿°, °ñ´Ù°øÁõ, °íÁöÇ÷Áõ) : 2019-11-02 |
0 |
441 |
2019-10-24 |
|
|
|
527 |
¼¿ï |
¼¼ºê¶õ½ºº´¿ø 2Çбâ À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ (¼Ò¾Æ ºÎºñµ¿¿° Ä¡·áÀÇ ³ëÇÏ¿ì) : 2019-11-28 |
0 |
440 |
2019-11-07 |
|
|
|
526 |
°æ±â |
2019³â ºÐ´çÂ÷º´¿ø ¼Ò¾Æû¼Ò³â°ú °³¿øÀÇ ¿¬¼ö°Á : 2019-11-17 |
0 |
438 |
2019-10-12 |
|
|
|
525 |
¼¿ï |
2019 ´ëÇѽŰæ¿Ü°úÀÇ»çȸ Ãß°èÇмú´ëȸ : 2019-11-24 |
0 |
437 |
2019-11-07 |
|
|